Breast neoplasms Clinical Trials

Delta Trials tracks 844 clinical trials for Breast neoplasms in its publicly accessible dataset. Among the listed trials, 117 open for participant enrollment and 450 trials have reached completion. This research is carried out at 2,857 clinical sites around the world. An additional 277 trials have active registrations outside the recruiting and completed categories. Since 2020, 81 trials have been terminated before reaching their primary endpoint. This dataset is refreshed continuously as trial statuses are updated on ClinicalTrials.gov, capturing longitudinal changes in the research landscape.